| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.5 |